Emmert M, Bonatti J, Caliskan E, Gaudino M, Grabenwoger M, Grapow M
Front Cardiovasc Med. 2024; 11:1285685.
PMID: 38476377
PMC: 10927966.
DOI: 10.3389/fcvm.2024.1285685.
Kottmann P, Eildermann K, Raj Murthi S, Cleuziou J, Lemmer J, Vitanova K
Mamm Genome. 2023; 34(2):285-297.
PMID: 36867212
PMC: 10290590.
DOI: 10.1007/s00335-023-09982-3.
Tilkorn D, Sorg H, Sanders A, Koller M, Awakowicz P, Hauser J
Innov Surg Sci. 2022; 6(3):97-104.
PMID: 35224177
PMC: 8826163.
DOI: 10.1515/iss-2021-0027.
Song B, Lee C, Park J, Kim B, Lee S, Lim S
Exp Ther Med. 2021; 23(1):21.
PMID: 34815773
PMC: 8593924.
DOI: 10.3892/etm.2021.10943.
Khachigian L
Int J Mol Sci. 2019; 20(21).
PMID: 31683712
PMC: 6861964.
DOI: 10.3390/ijms20215445.
A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells.
Seo H, Kim S, Lee C, Lim K, Lee J, Choi E
Biol Res. 2017; 50(1):1.
PMID: 28100269
PMC: 5244549.
DOI: 10.1186/s40659-016-0106-3.
Hypoxia Differentially Regulates Arterial and Venous Smooth Muscle Cell Migration.
Chanakira A, Kir D, Barke R, Santilli S, Ramakrishnan S, Roy S
PLoS One. 2015; 10(9):e0138587.
PMID: 26381529
PMC: 4575051.
DOI: 10.1371/journal.pone.0138587.
Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.
Hocking K, Luo W, Li F, Komalavilas P, Brophy C, Cheung-Flynn J
J Vasc Surg. 2015; 64(1):210-8.
PMID: 25704409
PMC: 4544660.
DOI: 10.1016/j.jvs.2014.12.059.
Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.
Voskresensky I, Wise E, Hocking K, Li F, Osgood M, Komalavilas P
JAMA Surg. 2014; 149(11):1176-81.
PMID: 25251505
PMC: 4237645.
DOI: 10.1001/jamasurg.2014.2029.
Perioperative use of eicosapentaenoic acid and patency of infrainguinal vein bypass: A retrospective chart review.
Mii S, Yamaoka T, Eguchi D, Okazaki J, Tanaka K
Curr Ther Res Clin Exp. 2014; 68(3):161-74.
PMID: 24683207
PMC: 3967272.
DOI: 10.1016/j.curtheres.2007.06.005.
Supplemental oxygen reverses hypoxia-induced smooth muscle cell proliferation by modulating HIF-alpha and VEGF levels in a rabbit arteriovenous fistula model.
Wan J, Lata C, Santilli A, Green D, Roy S, Santilli S
Ann Vasc Surg. 2013; 28(3):725-36.
PMID: 24345704
PMC: 3968233.
DOI: 10.1016/j.avsg.2013.10.007.
The protective effect of Bcl-xl overexpression against oxidative stress-induced vascular endothelial cell injury and the role of the Akt/eNOS pathway.
Ni L, Li T, Liu B, Song X, Yang G, Wang L
Int J Mol Sci. 2013; 14(11):22149-62.
PMID: 24217227
PMC: 3856057.
DOI: 10.3390/ijms141122149.
Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.
Osgood M, Hocking K, Voskresensky I, Li F, Komalavilas P, Cheung-Flynn J
J Vasc Surg. 2013; 60(1):202-11.
PMID: 23911244
PMC: 3926896.
DOI: 10.1016/j.jvs.2013.06.004.
Local drug delivery to prevent restenosis.
Seedial S, Ghosh S, Saunders R, Suwanabol P, Shi X, Liu B
J Vasc Surg. 2013; 57(5):1403-14.
PMID: 23601595
PMC: 3635112.
DOI: 10.1016/j.jvs.2012.12.069.
The role of short-term oxygen administration in the prevention of intimal hyperplasia.
Lata C, Green D, Wan J, Roy S, Santilli S
J Vasc Surg. 2013; 58(2):452-9.
PMID: 23380177
PMC: 3729739.
DOI: 10.1016/j.jvs.2012.11.041.
Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia.
Osgood M, Flynn C, Komalavilas P, Brophy C
Vascular. 2012; 21(1):46-53.
PMID: 23104826
PMC: 4180429.
DOI: 10.1258/vasc.2011.201203.
Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?.
Osgood M, Harrison D, Sexton K, Hocking K, Voskresensky I, Komalavilas P
Ann Vasc Surg. 2012; 26(8):1130-44.
PMID: 22445245
PMC: 4189806.
DOI: 10.1016/j.avsg.2011.12.001.
Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.
Muto A, Panitch A, Kim N, Park K, Komalavilas P, Brophy C
Vascul Pharmacol. 2011; 56(1-2):47-55.
PMID: 22024359
PMC: 3268886.
DOI: 10.1016/j.vph.2011.07.008.
Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins.
Hocking K, Brophy C, Rizvi S, Komalavilas P, Eagle S, Leacche M
J Vasc Surg. 2010; 53(2):454-60.
PMID: 21146345
PMC: 3053010.
DOI: 10.1016/j.jvs.2010.09.010.
A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.
Lopes L, Brophy C, Flynn C, Yi Z, Bowen B, Smoke C
J Vasc Surg. 2010; 52(6):1596-607.
PMID: 20864298
PMC: 3005888.
DOI: 10.1016/j.jvs.2010.06.168.
